Primary Care Diagnostics

05/01/2026

The COGNISION® System provides in-office ERP and EEG testing designed to support cognitive evaluation through objective physiologic measurement. During testing, patients wear a headset while brain responses to auditory stimuli are recorded. These responses offer insight into neural processing associated with attention and working memory, while resting EEG adds information about background brain activity.

Dementia evaluation is rarely straightforward Evaluating dementia in clinical practice often involves more than identifying memory loss alone. Early cognitive decline may present as slowed thinking, reduced attention, difficulty with working memory, or subtle changes in day-to-day functioning that a...

04/21/2026

Early cognitive decline can be difficult to detect when symptoms are mild or inconsistent. This short video explains how the COGNISION® System helps establish cognitive baselines through in-office ERP and EEG testing, giving providers objective data to support monitoring and earlier dementia detection over time.

04/14/2026

How do you track cardiometabolic risk beyond symptoms and routine lab work? This short video highlights how the TM Flow System provides objective in-office data to support long-term monitoring of vascular and nerve-related changes. It is a practical look at how trending physiologic data can strengthen chronic disease management and help guide earlier intervention.

04/07/2026

Establishing a cognitive baseline can make a meaningful difference when patients begin showing subtle signs of memory or processing changes. In our latest blog, we explore how the COGNISION® System supports baseline brain function testing in patients at risk for dementia through objective ERP and EEG data. These measurements can help clinicians track change over time and support earlier, more confident decision-making. Read the full blog here:

Why Cognitive Baselines Matter Cognitive decline often begins gradually, with subtle changes that may be difficult to detect during routine clinical visits. Patients may report occasional forgetfulness or slowed thinking, but early symptoms can overlap with normal aging or temporary stress. Without....

04/01/2026

Cardiometabolic disease often progresses long before major symptoms appear, which makes ongoing monitoring essential. In our latest blog, we look at how the TM Flow System helps providers track cardiometabolic risk over time through objective vascular and sudomotor data. By identifying trends in circulation and small fiber nerve function, clinicians can gain a clearer picture of improvement, stability, or decline and make more informed care decisions. Read the full blog here:

The Importance of Monitoring Cardiometabolic Health Cardiometabolic disease remains one of the most significant contributors to morbidity and mortality worldwide. Conditions such as diabetes, hypertension, and metabolic syndrome often develop gradually, with physiologic changes occurring long before...

03/20/2026

Objective ERP and EEG data allow you to detect abnormalities in cognitive processing that may not yet be evident on traditional screening tools. When patients present with early cognitive complaints, the COGNISION® System provides physiologic evidence that supports further evaluation, closer monitoring, or referral when appropriate.

This early insight is particularly valuable in patients with risk factors such as diabetes, cardiovascular disease, or family history of dementia.

03/11/2026

The TM Flow System integrates noninvasive vascular and nerve-related measurements into a single assessment. Vascular testing evaluates blood flow to the lower extremities and identifies peripheral arterial disease through objective perfusion values, helping detect vessel blockage that may not yet be clinically obvious.

Sudomotor testing assesses small fiber nerve function by measuring sweat gland activity, which is commonly impaired in neuropathic conditions associated with diabetes and metabolic disease.

When these data points are viewed together, clinicians can determine whether symptoms are primarily driven by vascular insufficiency, neuropathic dysfunction, or both, allowing for more precise clinical decision making.

03/07/2026

Lower extremity symptoms are among the most frequent and challenging complaints in patients with metabolic and cardiovascular disease. By distinguishing neuropathy from vascular blockage and providing ongoing insight into cardiometabolic health, the TM Flow System offers a practical solution for both diagnosis and long-term management.

https://primarycarediagnostics.com/using-the-tm-flow-system-to-differentiate-neuropathy-from-vascular-blockage-in-patients/

03/02/2026

Objective ERP and EEG data allow you to detect abnormalities in cognitive processing that may not yet be evident on traditional screening tools. When patients present with early cognitive complaints, the COGNISION® System provides physiologic evidence that supports further evaluation, closer monitoring, or referral when appropriate.

This early insight is particularly valuable in patients with risk factors such as diabetes, cardiovascular disease, or family history of dementia.

The Challenge of Recognizing Cognitive Decline Early Dementia frequently develops gradually, with early symptoms that may be subtle or easily attributed to normal aging. Patients often present with slowed thinking, difficulty with attention, or mild memory concerns long before significant impairment...

02/20/2026

Advancements in brain health management require tools that move beyond observation and into objective physiology. The COGNISION® System empowers neurology practices to document cognitive decline and brain injury recovery with clinical precision.

02/13/2026

Providing high-quality care for an aging population requires the best diagnostic tools available. If you are ready to integrate objective vascular and autonomic testing into your practice, the team at Primary Care Diagnostics is here to help.

02/08/2026

In the clinical management of neurodegenerative diseases and brain injuries, subjective patient reports and pen-and-paper screenings often fall short of providing a complete diagnostic picture. For conditions like Alzheimer’s Disease, various forms of Dementia, and Traumatic Brain Injury (TBI), traditional assessments may not detect underlying neurophysiological changes until significant functional decline has already occurred. This “diagnostic gap” is particularly prevalent in high-functioning patients with significant cognitive reserves who can mask deficits during standard exams.

The Challenge of Objective Assessment in Neurology In the clinical management of neurodegenerative diseases and brain injuries, subjective patient reports and pen-and-paper screenings often fall short of providing a complete diagnostic picture. For conditions like Alzheimer’s Disease, various form...